Live Oak Health Sciences (LOGSX)
* As of 31-Jan-16
Quotes delayed, except where indicated otherwise. Currency in USD.
|Morningstar Overall Rating:|
|Annual Report Expense Ratio (net):||1.08%|
Performance & Risk
|5y Avg Return:||15.71%|
|Rank in Category (ytd):||1|
|% Rank in Category (ytd):||0.78%|
|Morningstar Risk Rating:||1|
The investment seeks long-term capital growth.
The fund invests primarily in common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences. It will invest at least 80% of its net assets, under normal circumstances, in equity securities of health sciences companies. The fund invests primarily in common stocks of U.S. companies, but may, to a lesser extent, invest in common stocks of foreign companies and American Depositary Receipts ("ADRs") that meet the investment criteria of the fund. View More